We are seeking candidates for a NGS Bioinformatics programmer position with our client Mayo Clinic in Rochester, MN. Candidate will work in a team who are Developing tools necessary to implement a wide range of Next Generation Sequencing (NGS) tests from small gene panels to Whole Genome Sequencing, to the Epigenome and Microbiome tests. This is a one year position and could extend or hired as full-time employee at the end of the assignment. Required Qualifications are Next Generation Sequencing knowledge of software variant alignment and callers as well as methods and best practices. Working knowledge of Unix/Linux and experience with developing software pipelines that execute genetics tests from instrument data handling through Patient results analysis. Skilled in the validation and testing of NGS pipelines, generating Golden Data sets and working to verify fully functional systems. Background in creating and managing production IT solutions for Genetics and/or Bioinformatics a plus. Software development skills using Python, Bash scripting is required. Candidates will work in an Agile environment. Version Control, Software testing experience is required. If you are interested, please get in touch [email protected] or 507-289-9956. Thank you.
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
Latest Articles
Collapse
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
31 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|
||
Started by seqadmin, 04-10-2024, 10:19 PM
|
0 responses
32 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 10:19 PM
|
||
Started by seqadmin, 04-10-2024, 09:21 AM
|
0 responses
28 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 09:21 AM
|
||
Started by seqadmin, 04-04-2024, 09:00 AM
|
0 responses
53 views
0 likes
|
Last Post
by seqadmin
04-04-2024, 09:00 AM
|